FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/03/082947 [Registered on: 20/03/2025] Trial Registered Prospectively
Last Modified On: 19/03/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug 
Study Design  Cluster Randomized Trial 
Public Title of Study   Comparative study for the efficacy of aflibercept and dexamethasone implant in treatment naive macular edema with serous retinal detachment 
Scientific Title of Study   Comparative efficacy of Aflibercept and dexamethasone implant in treatment naive diabetic macular edema with serous retinal detachment:A prospective 6 month followup study 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Manglesh Mohan Gupta 
Designation  Fellow 
Affiliation  Nethradhama super speciality eye hospital  
Address  Retina Department, 1st floor, SPC block, Nethradhama eye hospital, Kanakpura road,7th block, Jayanagar
Retina Department, 1st floor, SPC block, Nethradhama eye hospital, Kanakpura road,7th block, Jayanagar
Bangalore
KARNATAKA
560076
India 
Phone    
Fax    
Email  manglesh11222@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Monika Kapoor 
Designation  Consultant vitreous retina 
Affiliation  Nethradhama super speciality eye hospital  
Address  Retina Department, 1st floor, SPC block, Nethradhama eye hospital, Kanakpura road,7th block, Jayanagar
Retina Department, 1st floor, SPC block, Nethradhama eye hospital, Kanakpura road,7th block, Jayanagar
Bangalore
KARNATAKA
560070
India 
Phone  9811866335  
Fax    
Email  dr.monika.kapoor@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Monika Kapoor 
Designation  Consultant vitreous retina 
Affiliation  Nethradhama super speciality eye hospital  
Address  Retina Department, 1st floor, SPC block, Nethradhama eye hospital, Kanakpura road,7th block, Jayanagar
Retina Department, 1st floor, SPC block, Nethradhama eye hospital, Kanakpura road,7th block, Jayanagar
Bangalore
KARNATAKA
560070
India 
Phone  9811866335  
Fax    
Email  dr.monika.kapoor@gmail.com  
 
Source of Monetary or Material Support  
Retina Department, 1st floor, SPC block, Nethradhama eye hospital, Kanakpura road,7th block, Jayanagar 
 
Primary Sponsor  
Name  Nethradhama education research foundation  
Address  Retina Department, 1st floor, SPC block, Nethradhama eye hospital, Kanakpura road,7th block, Jayanagar 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Manglesh Mohan Gupta  Nethradhama super speciality eye hospital   Retina Department, SPC Block, 1st floor, Nethradhama eye hospital, kanakpura road,7th block Jayanagar Bangalore
Bangalore
KARNATAKA 
9503586623

manglesh1122@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Ethics committee for research on human subjects   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: H350||Background retinopathy and retinalvascular changes,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Alfliebrrcept and Dexamethasone implant  Aflibercept 2mg/0.05ml intravitreal dose, duration 10mins Dexamethasone implant 0.7mg, intravitreal implant, intravitreal injection, duration 10mins 
Intervention  Intravitreal antivegf  Intravitreal anti vegf injection 
 
Inclusion Criteria  
Age From  20.00 Year(s)
Age To  80.00 Year(s)
Gender  Both 
Details  Diagnosis of DME treatment naive , Central retinal thickness more than 250 micrometer 
 
ExclusionCriteria 
Details  Prior intervention of disease
allergy to drug 
 
Method of Generating Random Sequence    
Method of Concealment    
Blinding/Masking    
Primary Outcome  
Outcome  TimePoints 
Measurement of mean central retinal thickness and mean change from baseline in Central retinal thickness and serous retinal detachment   Baseline, 1,3,6 months 
 
Secondary Outcome  
Outcome  TimePoints 
Mean Best corrected visual acuity  Baseline, 1 ,3, 6 months 
 
Target Sample Size   Total Sample Size="100"
Sample Size from India="100" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   30/03/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   Comparing the efficacy of Anti VEGF with steroid injection in newly diagnosed casea of Diabetic macular edema with Serous retinal detachment. To check which injection gives better response with less number of injections. 
Close